Here are four key takeaways:
1. Factors driving market growth include a higher prevalence of ankylosing spondylitis cases as well as rising awareness about diagnostics and treatments for the disease.
2. More government initiatives and efforts to improve healthcare infrastructure are fueling market growth.
3. The treatment’s escalated costs and a lack of surgeons and physiotherapists with ankylosing spondylitis expertise pose as barriers to market growth.
4. North America dominates the market because of a higher prevalence of the disease and more adoption of the disease’s treatment options.
More spine news:
17 spine, neurosurgeons on the move in August 2016
5 key notes on cost, readmissions for spinal tumor resection: Primary & metastatic
The best new opportunities for spine surgeons in value-based healthcare: Q&A with Dr. Stephen Hochschuler
At the Becker's 23rd Annual Spine, Orthopedic and Pain Management-Driven ASC + The Future of Spine Conference, taking place June 11-13 in Chicago, spine surgeons, orthopedic leaders and ASC executives will come together to explore minimally invasive techniques, ASC growth strategies and innovations shaping the future of outpatient spine care. Apply for complimentary registration now.
